Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
Sneham Tiwari, Venkata Atluri, Ajeet Kaushik, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 5541-5554
Open Access | Times Cited: 973

Showing 1-25 of 973 citing articles:

Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease
Periyanaina Kesika, Natarajan Suganthy, Bhagavathi Sundaram Sivamaruthi, et al.
Life Sciences (2020) Vol. 264, pp. 118627-118627
Closed Access | Times Cited: 359
Delivering the power of nanomedicine to patients today
Matthieu Germain, Fanny Caputo, Su Metcalfe, et al.
Journal of Controlled Release (2020) Vol. 326, pp. 164-171
Open Access | Times Cited: 304
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies
Myungjin Jo, Shinrye Lee, Yu‐Mi Jeon, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 10, pp. 1652-1662
Open Access | Times Cited: 256
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Ashwinipriyadarshini Megur, Daiva Baltriukienė, Virginija Bukelskienė, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 37-37
Open Access | Times Cited: 231
Imaging Techniques in Alzheimer’s Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring
Wieke M. van Oostveen, Elizabeth C. M. de Lange
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2110-2110
Open Access | Times Cited: 183
Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer's disease mouse model via regulating the gut microbiota-brain axis
Qing Liu, Yujia Xi, Qianxu Wang, et al.
Brain Behavior and Immunity (2021) Vol. 95, pp. 330-343
Closed Access | Times Cited: 154
Prospective therapeutic potential of Tanshinone IIA: An updated overview
Mohammad Azam Ansari, Mir Azam Khan, Haaris A. Safdari, et al.
Pharmacological Research (2020) Vol. 164, pp. 105364-105364
Closed Access | Times Cited: 143
Towards hospital-on-chip supported by 2D MXenes-based 5th generation intelligent biosensors
Vishal Chaudhary, Virat Khanna, Hafiz Taimoor Ahmed Awan, et al.
Biosensors and Bioelectronics (2022) Vol. 220, pp. 114847-114847
Open Access | Times Cited: 136
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Emily Connell, Gwénaëlle Le Gall, Matthew G. Pontifex, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 126
Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model
Xiaoyan Xu, Yaqin Sun, Xufeng Cen, et al.
Protein & Cell (2021) Vol. 12, Iss. 10, pp. 769-787
Open Access | Times Cited: 116
Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
Ana Rita Monteiro, Daniel José Barbosa, Fernando Remião, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115522-115522
Open Access | Times Cited: 115
Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review
Paulina Mikulska, Marta Malinowska, Miłosz Ignacyk, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1057-1057
Open Access | Times Cited: 108
Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113305-113305
Closed Access | Times Cited: 94
Periodontal microorganisms and Alzheimer disease – A causative relationship?
Gert Jungbauer, Alexandra Stähli, Xilei Zhu, et al.
Periodontology 2000 (2022) Vol. 89, Iss. 1, pp. 59-82
Open Access | Times Cited: 92
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
Erik Nutma, Nurun Fancy, Maria Weinert, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 87
Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: A review
Shinjini Bandopadhyay, Sujata Mandal, Mimosa Ghorai, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 5, pp. 593-608
Open Access | Times Cited: 85
Microbiota alteration and modulation in Alzheimer's disease by gerobiotics: The gut-health axis for a good mind
Duygu Ağagündüz, Betül Kocaadam‐Bozkurt, Tolga O. Bozkurt, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113430-113430
Open Access | Times Cited: 81
Ultrasound-mediated blood–brain barrier opening: An effective drug delivery system for theranostics of brain diseases
Jieqiong Wang, Zhenzhou Li, Min Pan, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114539-114539
Closed Access | Times Cited: 80
Tau accelerates α-synuclein aggregation and spreading in Parkinson’s disease
Lina Pan, Chunrui Li, Lanxia Meng, et al.
Brain (2022) Vol. 145, Iss. 10, pp. 3454-3471
Open Access | Times Cited: 78
Cannabidiol for neurodegenerative disorders: A comprehensive review
Sukanya Bhunia, Nagesh Kolishetti, Adriana Yndart, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 73
An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor
Annu, Ali Sartaj, Zufika Qamar, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 70
Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants
Prabhash Nath Tripathi, Ankit Lodhi, Sachchida Nand, et al.
Degenerative Neurological and Neuromuscular Disease (2024) Vol. Volume 14, pp. 47-74
Open Access | Times Cited: 53
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Anne‐Cathrine S. Vogt, Gary T. Jennings, Mona O. Mohsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3895-3895
Open Access | Times Cited: 52
Biomedical applications of MnO2 nanomaterials as nanozyme-based theranostics
Sajjad Sisakhtnezhad, Matin Rahimi, Soheila Mohammadi
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114833-114833
Open Access | Times Cited: 52
Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
Paras Mani Giri, Anurag Banerjee, Arpita Ghosal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3995-3995
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top